BRIDGEBIO ONCOLOGY THERAPEUT BBOT
COM NEW · Common Stock · CUSIP 107924102
- SectorHealth care
- IndustryPharmaceutical Preparations
- HeadquartersSouth San Francisco, CA
- FilingsSEC EDGAR
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $8.95.
Trends to Q1 2026
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q3 2025 | 42 |
| Q4 2025 | 53 |
| Q1 2026 | 67 |
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Numbers
| Quarter | Bought or added | Cut or sold out |
|---|---|---|
| Q4 2025 | 27 | 16 |
| Q1 2026 | 40 | 18 |
Biggest buyers
| ROYCE & ASSOCIATES LP | New | +636.5k |
| Laurion Capital Management LP | Added | +457.7k |
| Aisling Capital Management LP | Added | +453.4k |
| ARMISTICE CAPITAL, LLC | Added | +328.0k |
| Ensign Peak Advisors, Inc | New | +320.9k |
| SCHRODER INVESTMENT MANAGEMENT GROUP | New | +249.2k |
| Granahan Investment Management, LLC | New | +231.0k |
| NOVO HOLDINGS A/S | Added | +224.6k |
| Hudson Bay Capital Management LP | New | +110.0k |
| Avidity Partners Management LP | New | +87.7k |
Biggest sellers
| Paradigm Biocapital Advisors LP | Reduced | -1.4m |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | Reduced | -1.0m |
| EVENTIDE ASSET MANAGEMENT, LLC | Reduced | -541.2k |
| Catalio Capital Management, LP | Sold out | -410.7k |
| PRICE T ROWE ASSOCIATES INC /MD/ | Reduced | -365.2k |
| Octagon Capital Advisors LP | Reduced | -324.1k |
| ADAR1 Capital Management, LLC | Sold out | -226.2k |
| HighVista Strategies LLC | Reduced | -151.1k |
| WELLINGTON MANAGEMENT GROUP LLP | Reduced | -88.7k |
| STEMPOINT CAPITAL LP | Sold out | -86.5k |
Major shareholders (over 5%)
Anyone who owns more than 5% of a class of the company's shares has to say so: on Schedule 13D if they may try to influence or control the company, on 13G if they're a passive investor, and update it as the stake changes. Each holder's latest filing, from 19 Dec 2024 on; percentages are of the share class, as the holder worked them out.
| Holder | Stake |
|---|---|
Helix Holdings II LLC
13D · may seek influence
filed 2025-08-13
Stated purposeItem 4 is hereby amended and supplemented as follows: As previously disclosed, on February 28, 2025, the Issuer (which was formerly known as Helix Acquisition Corp. II, "Helix") entered into a Business Combination Agreement (as amended on June 20, 2025, the "Business Combination Agreement") with TheRas, Inc. (d/b/a BridgeBio Oncology Therapeutics, "Legacy BBOT"), and Helix II Merger Sub, Inc. ("Merger Sub"), pursuant to which, subject to the satisfaction or waiver of certain conditions set forth therein, the Domestication of Helix as a Delaware corporation would occur, followed by the Merger of Merger Sub with and into Legacy BBOT. Prior to the Business Combination, Ms. Chen was the Chairwoman and Chief Executive Officer of the Issuer, a shareholder of the Issuer, and a shareholder of Leg… Full filing |
22.6% |
Chen Bihua
13D · may seek influence
filed 2026-07-06
Stated purposeItem 4 is hereby amended and supplemented as follows: On July 1, 2026, Sponsor distributed 4,528,186 shares of Common Stock, pro rata, to its members for no consideration. Following such transaction, Sponsor holds no shares of Common Stock. As a result of Sponsor's pro rata distribution of shares to its members, (i) Fund III, a member of Sponsor, acquired 2,692,459 shares of Common Stock; (ii) Fund V, a member of Sponsor, acquired 1,704,862 shares of Common Stock; and (iii) Master Fund, a member of Sponsor, acquired 130,865 shares of Common Stock. Full filing |
22.3% |
BridgeBio Pharma LLC
13D · may seek influence
new · filed 2025-08-18
Stated purposeThe Reporting Persons acquired the Shares for investment purposes in the ordinary course of business. Immediately following the Effective Time of the Business Combination, Neil Kumar, Ph.D., Chief Executive Officer and a member of the board of directors of BBIO, and Frank P. McCormick, Ph.D., F.R.S., D.Sc., Chairman of Oncology and a member of the board of directors of BBIO, were appointed to serve as directors of the Issuer. As a result of their positions, Drs. Kumar and McCormick may, from time to time, engage in discussions with the Issuer's board of directors, management, or other stockholders regarding matters relating to the Issuer's business, operations, governance, strategy, or capital structure. These discussions may include, but are not limited to: (i) the acquisition or dispos… Full filing |
17.5% |
| BlackRock Portfolio Management LLC 13G · institution new · filed 2025-04-15 | 7.9% |
| Flynn James E 13G · passive investor new · filed 2025-08-18 | 6.2% |
| BC Global Opportunities IX LP 13G · passive investor new · filed 2025-09-03 | 5.5% |
Insider purchases and sales in Q1 2026
Shares bought or sold by the company's own officers, directors and 10% owners, in the open market or privately, as they reported to the SEC on Form 4 (due within two business days of the trade). Grants, option exercises, shares withheld for tax and gifts aren't included.
None reported in Q1 2026.
Holders, Q1 2026
| Manager | Shares | Change |
|---|---|---|
| Cormorant Asset Management, LP 8.07% of their portfolio | 17.9m $160.0m | Unchanged |
| DEERFIELD MANAGEMENT COMPANY, L.P. 0.52% of their portfolio | 4.9m $43.7m | Unchanged |
| Omega Fund Management, LLC 18.05% of their portfolio | 3.3m $29.4m | Unchanged |
| EcoR1 Capital, LLC 1.08% of their portfolio | 2.8m $25.3m | Unchanged |
| Alphabet Inc. 0.63% of their portfolio | 2.8m $25.3m | Unchanged |
| WELLINGTON MANAGEMENT GROUP LLP 0.00% of their portfolio | 2.8m $25.2m | Reduced -88.7k |
| ENAVATE SCIENCES GP, LLC 6.69% of their portfolio | 2.6m $23.5m | Unchanged |
| CITADEL ADVISORS LLC 0.02% of their portfolio | 2.5m $22.6m | Reduced -1.6k |
| NOVO HOLDINGS A/S 1.59% of their portfolio | 2.2m $19.6m | Added +224.6k |
| BlackRock, Inc. 0.00% of their portfolio | 2.1m $18.7m | Added +3.5k |
| Laurion Capital Management LP 1.61% of their portfolio | 1.9m $17.2m | Added +457.7k |
| ARMISTICE CAPITAL, LLC 0.39% of their portfolio | 1.3m $11.9m | Added +328.0k |
| Aisling Capital Management LP 1.91% of their portfolio | 1.0m $9.1m | Added +453.4k |
| Paradigm Biocapital Advisors LP 0.16% of their portfolio | 868.2k $7.8m | Reduced -1.4m |
| Octagon Capital Advisors LP 0.71% of their portfolio | 719.0k $6.4m | Reduced -324.1k |
| ROYCE & ASSOCIATES LP 0.06% of their portfolio | 636.5k $5.7m | New |
| GEODE CAPITAL MANAGEMENT, LLC 0.00% of their portfolio | 579.2k $5.2m | Added +17.2k |
| EVENTIDE ASSET MANAGEMENT, LLC 0.08% of their portfolio | 541.2k $4.7m | Reduced -541.2k |
| VANGUARD CAPITAL MANAGEMENT LLC 0.00% of their portfolio | 538.4k $4.8m | First filing |
| PRICE T ROWE ASSOCIATES INC /MD/ 0.00% of their portfolio | 437.9k $3.9m | Reduced -365.2k |
| ADAGE CAPITAL PARTNERS GP, L.L.C. 0.01% of their portfolio | 400.0k $3.6m | Reduced -1.0m |
| Ensign Peak Advisors, Inc 0.01% of their portfolio | 320.9k $2.9m | New |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC 0.00% of their portfolio | 290.8k $2.6m | Added +11.8k |
| Casdin Capital, LLC 0.19% of their portfolio | 282.3k $2.5m | Unchanged |
| Ikarian Capital, LLC 0.35% of their portfolio | 270.2k $2.4m | Added +50.0k |
| MILLENNIUM MANAGEMENT LLC 0.00% of their portfolio | 266.0k $2.4m | Added +24.5k |
| VANGUARD FIDUCIARY TRUST CO 0.00% of their portfolio | 254.3k $2.3m | First filing |
| SCHRODER INVESTMENT MANAGEMENT GROUP 0.00% of their portfolio | 249.2k $2.2m | New |
| FMR LLC 0.00% of their portfolio | 240.3k $2.2m | Unchanged |
| Granahan Investment Management, LLC 0.10% of their portfolio | 231.0k $2.1m | New |
| STATE STREET CORP 0.00% of their portfolio | 226.3k $2.0m | Added +8.0k |
| GOLDMAN SACHS GROUP INC 0.00% of their portfolio | 167.6k $1.5m | Added +72.9k |
| Sio Capital Management, LLC 0.17% of their portfolio | 130.6k $1.2m | Unchanged |
| Hudson Bay Capital Management LP 0.01% of their portfolio | 110.0k $984.5k | New |
| Woodline Partners LP 0.00% of their portfolio | 103.7k $928.2k | Unchanged |
| NORTHERN TRUST CORP 0.00% of their portfolio | 102.3k $915.2k | Added +44.2k |
| RENAISSANCE TECHNOLOGIES LLC 0.00% of their portfolio | 101.9k $912.0k | Added +27.6k |
| MOORE CAPITAL MANAGEMENT, LP 0.03% of their portfolio | 100.0k $895.0k | Unchanged |
| BNP PARIBAS FINANCIAL MARKETS 0.00% of their portfolio | 90.8k $812.8k | Added +64.3k |
| Avidity Partners Management LP 0.08% of their portfolio | 87.7k $761.3k | New |
| Tidal Investments LLC 0.00% of their portfolio | 82.2k $735.4k | New |
| Tema ETFs LLC 0.05% of their portfolio | 82.2k $735.4k | New |
| BOOTHBAY FUND MANAGEMENT, LLC 0.02% of their portfolio | 80.9k $723.9k | Added +13.8k |
| HighVista Strategies LLC 0.19% of their portfolio | 78.2k $699.8k | Reduced -151.1k |
| Qube Research & Technologies Ltd 0.00% of their portfolio | 71.9k $643.7k | Added +36.0k |
| XTX Topco Ltd 0.01% of their portfolio | 59.7k $534.7k | Added +31.1k |
| TD Asset Management Inc 0.00% of their portfolio | 57.6k $515.3k | Reduced -59.6k |
| Opaleye Management Inc. 0.06% of their portfolio | 53.3k $476.9k | New |
| UBS Group AG 0.00% of their portfolio | 50.5k $451.5k | Reduced -42.9k |
| ExodusPoint Capital Management, LP 0.00% of their portfolio | 48.1k $430.7k | New |
| MORGAN STANLEY 0.00% of their portfolio | 43.4k $388.2k | Added +29.0k |
| Squarepoint Ops LLC 0.00% of their portfolio | 43.2k $386.6k | Added +31.7k |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE 0.00% of their portfolio | 35.7k $319.4k | Reduced -18.5k |
| ACADIAN ASSET MANAGEMENT LLC 0.00% of their portfolio | 29.1k $260.0k | New |
| Vanguard Global Advisers, LLC 0.00% of their portfolio | 18.2k $162.6k | First filing |
| AXQ CAPITAL, LP 0.02% of their portfolio | 17.3k $155.3k | New |
| Diametric Capital, LP 0.04% of their portfolio | 16.3k $145.7k | New |
| Brevan Howard Capital Management LP 0.00% of their portfolio | 14.2k $127.5k | New |
| Quadrature Capital Ltd 0.00% of their portfolio | 13.4k $119.5k | Added +429 |
| Aquatic Capital Management LLC 0.00% of their portfolio | 11.8k $105.5k | New |
| Bellevue Group AG 0.00% of their portfolio | 7.0k $62.5k | New |
| Rockefeller Capital Management L.P. 0.00% of their portfolio | 700 $6.3k | Unchanged |
| Accent Capital Management, LLC 0.00% of their portfolio | 335 $3.0k | New |
| WELLS FARGO & COMPANY/MN 0.00% of their portfolio | 300 $2.7k | Unchanged |
| BARCLAYS PLC 0.00% of their portfolio | 212 $1.9k | New |
| ROYAL BANK OF CANADA 0.00% of their portfolio | 154 $1.0k | New |
| Caitong International Asset Management Co., Ltd 0.00% of their portfolio | 4 $36 | New |